Prevalence and incidence of primary biliary cirrhosis are increasing in Finland

References

• Kaplan MM. Primary biliary cirrhosis [review]. N Engl J Med. 2005; 353: 1261–73
   PubMed Web of Science ®Google Scholar
• Prince MI, James OF. The epidemiology of primary biliary cirrhosis [review]. Clin Liver Dis 2003; 7: 795–819
   PubMedGoogle Scholar
• Gerschwin ME, Selmi C, Worman HJ, Gold EB, Watnik M, Utts J, and the USA PBC Epidemiology Group, et al. Risk Factors and comorbioites in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 2005; 42: 1194–202.
   PubMedGoogle Scholar
• Kim WR, Lindor KD, Locke GR III, Therneau TM, Homburger HA, Batts KP, et al. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology 2000; 11: 1631–6
   Google Scholar
• Sood S, Gow PJ, Christie JM, Angus PW. Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations. Gastroenterology 2004; 127: 470–5
   PubMed Web of Science ®Google Scholar
• James OF, Bhopal R, Howel D, Gray J, Burt AD, Metcalf JV. Primary biliary cirrhosis once rare, now common in the United Kingdom?. Hepatology 1999; 30: 390–4
   PubMed Web of Science ®Google Scholar
• Eriksson S, Lindgren S. The prevalence and clinical spectrum of primary biliary cirrhosis in a defined population in Sweden. Scand J Gastroenterol 1984; 19: 971–6
   PubMed Web of Science ®Google Scholar
• Lofgren J, Jarnerot G, Danielsson D, Hemdal I. Incidence and prevalence of primary biliary cirrhosis in a defined population in Sweden. Scand J Gastroenterol 1985; 20: 647–50
   PubMed Web of Science ®Google Scholar
• Danielsson A, Boqvist L, Uddenfeldt P. Epidemiology of primary biliary cirrhosis in a defined rural population in the northern part of Sweden. Hepatology 1990; 11: 458–64
   PubMed Web of Science ®Google Scholar
• Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 1998; 33: 99–103
   PubMed Web of Science ®Google Scholar
• Remmel T, Remmel H, Uibo R, Salupere V. Primary biliary cirrhosis in Estonia. With special reference to incidence, prevalence, clinical features, and outcome. Scand J Gastroenterol 1995; 30: 367–71
   PubMed Web of Science ®Google Scholar
• Almdal TP, Sorensen TI. Incidence of parenchymal liver diseases in Denmark, 1981 to 1985: analysis of hospitalization registry data. The Danish Association for the Study of the Liver. Hepatology 1991; 13: 650–5
   PubMed Web of Science ®Google Scholar
• Waterhouse J, Muir C, Correo P, Powell. Cancer incidence in five continents. Vol 11. Lyon: IARC Scientific Publications no. 15, International Agency for Research on Cancer; 1976.
   Google Scholar
• SAS Istitute, Inc. User's guide, statistics, Version 8. Gary, NC: 1999.
   Google Scholar
• Corpechot C, Carrat F, Bahr A, Chretien Y, Poupon RE, Poupon R. The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology 2005; 128: 297–303
   PubMed Web of Science ®Google Scholar
• Pares A, Caballeria L, Rodes J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid. Gastroenterology 2006; 130: 715–20
   PubMed Web of Science ®Google Scholar
• ter Borg PC, Schalm SW, Hansen BE, van Buuren HR; Dutch PBC Study Group. Prognosis of ursodeoxycholic aAcid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients. Am J Gastroenterol 2006;101:2044–50.
   Google Scholar
• www.scandiatransplant.org.
   Google Scholar
• www.eltr.org.
   Google Scholar
• Parikh-Patel A, Gold EB, Worman H, Krivy Ke, Gershwin ME. Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center. Hepatology 2001;33:16–21.
   PubMed Web of Science ®Google Scholar
• Selmi C, Gerschwin EM. Bacteria and human autoimmunity: the case of primary biliary cirrhosis. Curr Opin Rheumatol 2004; 16: 406–10
   PubMed Web of Science ®Google Scholar
• Selmi C, Balkwill DL, Invernizzi P, Ansari AA, et al. Patients with primary biliary cirrhosis reacts against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 2003; 38: 1250–7
   PubMed Web of Science ®Google Scholar
• Long SA, Quan C, Van de Water J, Nantz Mh, Kurth Mj, Barsky D, et al. Immunoreactivity of organic mimeotypes of E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis. J Immunol 2001; 167: 2956–63
   PubMed Web of Science ®Google Scholar
• Ala A, Stanca CM, Bu-Ghanim M, Ahmado I, Branch AD, Schiano TD, et al. Increased prevalence of primary biliary cirrhosis near superfund toxic waste sites. Hepatology 2006; 43: 525–31
   PubMed Web of Science ®Google Scholar
• Juran BD, Lazaridis KN. Genetics and complex liver diseases: challenges and opportunities. Hepatology 2006; 44: 1380–90
   PubMedGoogle Scholar
• Jones De, Watt Fe, Metcalf JV, Bassendine Mf, James Of. Familial primary biliary cirrhosis reassessed: a geographically based population study. J Hepatol 1999;30:402–7.
   PubMedGoogle Scholar
• Selmi C, Mayo MJ, Bach N, Ishibashi H, Invernizzi P, Gish RG, et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 2004; 127: 485–92
   PubMed Web of Science ®Google Scholar